These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2934021

  • 1. Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.
    Strunk RW, Gratz JC, Maserati R, Scheld WM.
    Antimicrob Agents Chemother; 1985 Sep; 28(3):428-32. PubMed ID: 2934021
    [Abstract] [Full Text] [Related]

  • 2. In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
    Bayer AS, Kim KS.
    Chemotherapy; 1986 Sep; 32(4):364-73. PubMed ID: 2942342
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa.
    Thauvin C, Lecomte F, Le Boete I, Grise G, Lemeland JF.
    Infection; 1989 Sep; 17(1):31-4. PubMed ID: 2493429
    [Abstract] [Full Text] [Related]

  • 4. Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
    Bayer AS, Blomquist IK, Kim KS.
    J Antimicrob Chemother; 1986 May; 17(5):641-9. PubMed ID: 2941403
    [Abstract] [Full Text] [Related]

  • 5. Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis.
    Johnson M, Miniter P, Andriole VT.
    J Infect Dis; 1987 Apr; 155(4):783-8. PubMed ID: 3102631
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Combined application of ciprofloxacin and tobramycin on mutant selective windows of ciprofloxacin against Pseudomonas aeruginosa].
    Liu MT, Sheng MY, Zhang Y, Li Y.
    Zhonghua Yi Xue Za Zhi; 2011 May 31; 91(20):1427-31. PubMed ID: 21756818
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics.
    Navas D, Caillon J, Gras-Le Guen C, Jacqueline C, Kergueris MF, Bugnon D, Potel G.
    J Antimicrob Chemother; 2004 Oct 31; 54(4):767-71. PubMed ID: 15317741
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.
    Norden CW, Shinners E.
    J Infect Dis; 1985 Feb 31; 151(2):291-4. PubMed ID: 3155780
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ciprofloxacin: comparative data in cystic fibrosis.
    Rubio TT.
    Am J Med; 1987 Apr 27; 82(4A):185-8. PubMed ID: 3555034
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
    Chin NX, Jules K, Neu HC.
    Eur J Clin Microbiol; 1986 Feb 27; 5(1):23-8. PubMed ID: 2938945
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA, Gerding DN, Peterson LR.
    Am J Med; 1987 Apr 27; 82(4A):44-54. PubMed ID: 3107380
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.